脑梗死急性期24 h血压变异与患者早、中期预后的关系研究

被引:16
作者
石铸
钟淑君
李淑恩
郑伟城
李瑞兰
机构
[1] 东莞市人民医院神经内科
关键词
脑卒中; 血压变异; 预后;
D O I
暂无
中图分类号
R743.31 [短暂性脑缺血];
学科分类号
1002 ;
摘要
目的探讨脑梗死急性期24 h血压变异和卒中早期及中期功能预后的关系。方法采用病例对照的研究方法, 连续登记自2013年1月至2015年12月在东莞市人民医院卒中中心住院治疗的急性脑梗死患者, 动态监测入院后24 h血压并计算血压变异参数, 采用改良Rankin(mRS)量表对患者出院时(早期)和6个月后(中期)预后进行评价(mRS评分≤2分为预后良好, mRS评分>2分为预后不良)。比较不同预后患者临床特征和血压参数, 建立二元Logistic回归模型分析血压变异参数与早期、中期不同预后的关系。结果研究共纳入188例患者, 早期预后不良67例(35.6%), 中期预后不良95例(50.5%)。早期预后不良组患者24 h平均收缩压和收缩压变异系数高于预后良好组患者[(149.6±20.0) mmHgvs. (137.6±20.2) mmHg;(13.4±3.8) mmHgvs. (12.1±3.8) mmHg], 差异有统计学意义(P<0.05)。多因素校正后提示, 24 h收缩压的均值和标准差增大是早期预后不良的独立预测因子(OR=1.284, 95%CI=1.067~1.544, P=0.008;OR=1.098, 95%CI=1.016~1.188, P=0.019)。中期预后不良组患者24 h收缩压均值大于预后良好组患者[(146.6±20.6) mmHgvs. (137.1±20.2) mmHg], 差异有统计学意义(P<0.05), 是中期预后不良的独立预测因子(OR=1.198, 95%CI=1.005~1.427, P=0.043)。结论 24 h收缩压变异增大是急性脑梗死早期预后不良的独立危险因素, 与脑梗死后中期预后无明显相关。
引用
收藏
页码:682 / 687
页数:6
相关论文
共 15 条
[1]   急性脑卒中患者预后相关因素分析 [J].
王娟 ;
蔡文智 ;
王静新 ;
张晓梅 ;
潘速跃 .
中华神经医学杂志, 2015, 14 (09) :927-931
[2]  
Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke.[J].Lisa S. Manning;Peter M. Rothwell;John F. Potter;Thompson G. Robinson.Stroke.2015, 9
[3]   Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension [J].
Levi-Marpillat, Natacha ;
Macquin-Mavier, Isabelle ;
Tropeano, Anne-Isabelle ;
Parati, Gianfranco ;
Maison, Patrick .
HYPERTENSION RESEARCH, 2014, 37 (06) :585-590
[4]   The prognostic value of long-term visit-to-visit blood pressure variability on stroke in real-world practice: A dynamic cohort study in a large representative sample of Chinese hypertensive population [J].
Yu, Jin-ming ;
Kong, Qun-yu ;
Schoenhagen, Paul ;
Shen, Tian ;
He, Yu-song ;
Wang, Ji-wei ;
Zhao, Yan-ping ;
Shi, Dan-ni ;
Zhong, Bao-liang .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 177 (03) :995-1000
[5]   Effects of Immediate Blood Pressure Reduction on Death and Major Disability in Patients With Acute Ischemic Stroke The CATIS Randomized Clinical Trial [J].
He, Jiang ;
Zhang, Yonghong ;
Xu, Tan ;
Zhao, Qi ;
Wang, Dali ;
Chen, Chung-Shiuan ;
Tong, Weijun ;
Liu, Changjie ;
Xu, Tian ;
Ju, Zhong ;
Peng, Yanbo ;
Peng, Hao ;
Li, Qunwei ;
Geng, Deqin ;
Zhang, Jintao ;
Li, Dong ;
Zhang, Fengshan ;
Guo, Libing ;
Sun, Yingxian ;
Wang, Xuemei ;
Cui, Yong ;
Li, Yongqiu ;
Ma, Dihui ;
Yang, Guang ;
Gao, Yanjun ;
Yuan, Xiaodong ;
Bazzano, Lydia A. ;
Chen, Jing .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (05) :479-489
[6]   Unsolved Issues in the Management of High Blood Pressure in Acute Ischemic Stroke [J].
Hubert, Gordian J. ;
Mueller-Barna, Peter ;
Haberl, Roman L. .
INTERNATIONAL JOURNAL OF HYPERTENSION, 2013, 2013
[7]   Different Impacts of Blood Pressure Variability on the Progression of Cerebral Microbleeds and White Matter Lesions [J].
Liu, Wenhong ;
Liu, Ran ;
Sun, Wei ;
Peng, Qing ;
Zhang, Weiwei ;
Xu, En ;
Cheng, Yan ;
Ding, Meiping ;
Li, Yansheng ;
Hong, Zhen ;
Wu, Jiang ;
Zeng, Jinsheng ;
Yao, Chen ;
Huang, Yining .
STROKE, 2012, 43 (11) :2916-U253
[8]   Effects of 24-Hour Blood Pressure and Heart Rate Recorded With Ambulatory Blood Pressure Monitoring on Recovery From Acute Ischemic Stroke [J].
Tomii, Yasuhiro ;
Toyoda, Kazunori ;
Suzuki, Rieko ;
Naganuma, Masaki ;
Fujinami, Jun ;
Yokota, Chiaki ;
Minematsu, Kazuo .
STROKE, 2011, 42 (12) :3511-3517
[9]   Blood Pressure Management in Acute Stroke Does the Scandinavian Candesartan Acute Stroke Trial (SCAST) Resolve All of the Unanswered Questions? [J].
Fischer, Urs ;
Rothwell, Peter M. .
STROKE, 2011, 42 (10) :2995-2998
[10]   The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial [J].
Sandset, Else Charlotte ;
Bath, Philip M. W. ;
Boysen, Gudrun ;
Jatuzis, Dalius ;
Korv, Janika ;
Lueders, Stephan ;
Murray, Gordon D. ;
Richter, Przemyslaw S. ;
Roine, Risto O. ;
Terent, Andreas ;
Thijs, Vincent ;
Berge, Eivind .
LANCET, 2011, 377 (9767) :741-750